Clinical Oncology Next-Generation Sequencing Market Report Overview:
The research provides a complete study of insights into the Clinical Oncology Next-Generation Sequencing Market, covering dynamic patterns, industry landscape, and all major market elements. The Clinical Oncology Next-Generation Sequencing market research also includes a detailed analysis of leading players.
Next-generation sequencing is a technique for sequencing DNA or RNA that allows several reactions to be carried out simultaneously. One of the most significant uses of next-generation sequencing in oncology. NGS has revolutionized cancer genetics in recent years by supplying researchers with access to genomic and transcriptomic data.
Grab your free sample copy of this report now @ https://www.maximizemarketresearch.com/request-sample/100383
Estimated Revenue Growth:
The Clinical Oncology Next-Generation Sequencing market size was valued at US $ 7.86 Bn.in 2022 and the total revenue is expected to grow at 20.7% through 2022 to 2029, reaching nearly US$ 2.93 Bn.
Clinical Oncology Next-Generation Sequencing Market Scope and Research Methodology:
The aim of this report is to assess and predict the size of the Clinical Oncology Next-Generation Sequencing market. It offers strategic profiles of significant market participants to provide an accurate depiction of the competitive landscape within the global Clinical Oncology Next-Generation Sequencing market. This includes a comprehensive analysis of recent developments such as new product launches, acquisitions, mergers, joint ventures, brand activities, and major players in the Clinical Oncology Next-Generation Sequencing industry. The report presents insights into industry trends, dynamics, and potentials, assisting professionals in staying informed about the latest trends and sector performance. This insight aids in predicting growth and decline in Clinical Oncology Next-Generation Sequencing market share over the forecast period.
In-depth understanding of the Clinical Oncology Next-Generation Sequencing industry was achieved through a combination of primary and secondary research methods. Various methodologies, including PESTLE, PORTER, and SWOT analysis, were employed to ensure accurate findings. SWOT analysis was employed to outline strengths, weaknesses, opportunities, and challenges for key players within the Clinical Oncology Next-Generation Sequencing industry. Additionally, the use of PORTER and PESTLE analysis allowed for an understanding of the microeconomic and macroeconomic factors influencing the Clinical Oncology Next-Generation Sequencing industry.
Market Dynamics:
The clinical oncology next-generation sequencing market is likely to lead in the next years, owing to increased cancer prevalence and technological breakthroughs in the field of next-generation sequencing. Furthermore, throughout the projected period, an increase in the preference for NGS over single-gene research is expected to generate significant market potential prospects.
According to the American Cancer Society, 1.7 million new cancer diagnoses and 0.6 million deaths occurred in the United States in 2019. Lung, prostate, bladder, and female breast cancer are the four most common types of cancer worldwide, accounting for 43% of all new cases. As a result, the global growth in cancer incidence rates is predicted to drive up demand for clinical oncology next-generation sequencing.
For a deeper understanding, click on the link below:
Clinical Oncology Next-Generation Sequencing Market Segmentation:
by Technology
• Whole Genome Sequencing
• Whole Exome Sequencing
• Targeted Sequencing & Resequencing Centrifuges
Based on technology, the targeted sequencing and resequencing segment grew significantly, accounting for more than 72% of total revenues in 2020. Targeted cancer sequencing panels tend to reduce the cost, time, and volume of data analysed during tumour sample sequencing. Furthermore, tailored panels’ capacity to detect malignant tumours enhances their therapeutic efficacy. NGS panels are clinically effective in 64% of cancer cases, according to a 2020 JCO Precision Oncology analysis.
by Workflow
• Pre Sequencing
• Sequencing
• Data Analysis
According to Workflow, sequencing was the most profitable workflow category, accounting for more than 54% of overall revenue. Sequencing is a critical step in the workflow that necessitates the usage of specialised platforms. The segment’s growth is boosted by an increase in the number of cancer sequencing programmes. The pre-sequencing portion is motivated by major participants’ desire to lower the cost of NGS library planning. The usage of NGS data analysis is projected to increase. The segment’s growth is supported by leading industry players’ attempts to build powerful analytical tools. The Pan-Cancer Analysis of Whole Genomes (PCAWG) Consortium sequenced more than 2,600 tumour samples from 38 distinct cancer types.
by Application
• Screening
• Companion Diagnostics
• Other Diagnostics
by End-User
• Hospitals
• Clinics
• Laboratories
Clinical Oncology Next-Generation Sequencing Market Key Players:
• Illumina, Inc.
• QIAGEN
• Thermo Fisher Scientific, Inc.
• F. Hoffman-La Roche Technologies
• Agilent Technologies
• Myriad Genetics
• Foundation Medicine
• Pacific Bioscience
• Oxford Nanopore Technologies Ltd.
• Beijing Genomics Institute (BGI)
• Perkin Elmer, Inc.
• Paradigm Diagnostics
• Caris Life Sciences
• Partek, Inc.
• Eurofins Scientific S.E.
• Bio Rad Laboratories, Inc.
• Other Key Players
Clinical Oncology Next-Generation Sequencing Market Regional Perspectives:
The report is segmented into several key countries, with market size, growth rate, import and export of Clinical Oncology Next-Generation Sequencing market in these countries, which covering North America, U.S., Canada, Mexico, Europe, UK, Germany, France, Spain, Italy, Rest of Europe, Asia Pacific, China, India, Japan, Australia, South Korea, ASEAN Countries, Rest of APAC, South America, Brazil, and Middle East and Africa.
Request For Sample Link: https://www.maximizemarketresearch.com/request-sample/100383
Key Questions answered in the Clinical Oncology Next-Generation Sequencing Market Report are:
- Which segment grabbed the largest share in the Clinical Oncology Next-Generation Sequencing market?
- Which segment is expected to grow at a high rate during the forecast period?
- How is the competitive scenario of the Clinical Oncology Next-Generation Sequencing market?
- Which are the key factors driving the Clinical Oncology Next-Generation Sequencing market growth?
- Which are the factors restraining the Clinical Oncology Next-Generation Sequencing market growth?
- Which region holds the maximum share in the Clinical Oncology Next-Generation Sequencing market?
- What will be the CAGR of the Clinical Oncology Next-Generation Sequencing market during the forecast period?
- Which are the prominent players in the Clinical Oncology Next-Generation Sequencing market?
Key Offerings:
- A detailed Analysis of the Market Overview
- Market Share, Size & Forecast by Revenue | 2024−2030
- Market Dynamics – Growth Drivers, Restraints, Investment Opportunities, and Key Trends
- Market Segmentation – A detailed analysis by Route of administration, Application, Facility of use and Region and Region
- Competitive Landscape – Top Key Vendors and Other Prominent Vendors
Table of Content: Clinical Oncology Next-Generation Sequencing Market
Part 01: Executive Summary
Part 02: Scope of the Clinical Oncology Next-Generation Sequencing Market Report
Part 03: Clinical Oncology Next-Generation Sequencing Market Landscape
Part 04: Clinical Oncology Next-Generation Sequencing Market Sizing
Part 05: Clinical Oncology Next-Generation Sequencing Market Segmentation by Type
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Related Reports:
Global Duty-Free Liquor Market https://www.maximizemarketresearch.com/market-report/global-duty-free-liquor-market/94512/
Global Black Cumin Seed Oil Market https://www.maximizemarketresearch.com/market-report/global-black-cumin-seed-oil-market/83552/
About Maximize Market Research:
Maximize Market Research is a multifaceted market research and consulting company with professionals from several industries. Some of the industries we cover include medical devices, pharmaceutical manufacturers, science and engineering, electronic components, industrial equipment, technology and communication, cars and automobiles, chemical products and substances, general merchandise, beverages, personal care, and automated systems. To mention a few, we provide market-verified industry estimations, technical trend analysis, crucial market research, strategic advice, competition analysis, production and demand analysis, and client impact studies.
Contact Maximize Market Research:
3rd Floor, Navale IT Park, Phase 2
Pune Banglore Highway, Narhe,
Pune, Maharashtra 411041, India
+91 96071 95908, +91 9607365656
